Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 1, 2011, Pages 40-47

  Rush, Craig R ^a,b   Stoops, William W ^a,b   Lile, Joshua A ^a   Glaser, Paul E A ^a,b   Hays, Lon R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Atomoxetine; Humans; Methamphetamine; Pharmacotherapy; Physiological effects; Subjective effects

Indexed keywords

ATOMOXETINE; DOPAMINE; METHAMPHETAMINE; NORADRENALIN TRANSPORTER; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; TEMPERATURE;

ADMINISTRATION, INTRANASAL; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HEART RATE; HUMANS; METHAMPHETAMINE; PROPYLAMINES; PSYCHOMOTOR PERFORMANCE; TIME FACTORS;

EID: 80051589795     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.06.024     Document Type: Article

References (48)

1. F.P. Bymaster, J.S. Katner, D.L. Nelson, S.K. Hemrick-Luecke, P.G. Threlkeld, and J.H. Heiligenstein Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 27 2002 699 711 (Pubitemid 35335888)
2. S.R. Chamberlain, N. Del Campo, J. Dowson, U. Muller, L. Clark, and T.W. Robbins Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder Biol Psychiatry 62 2007 977 984 (Pubitemid 47562368)
3. S.D. Comer, J.B. Ashworth, R.W. Foltin, C.E. Johanson, J.P. Zacny, and S.L. Walsh The role of human drug self-administration procedures in the development of medications Drug Alcohol Depend 96 2008 1 15
4. A. Elkashef, F. Vocci, G. Hanson, J. White, W. Wickes, and J. Tiihonen Pharmacotherapy of methamphetamine addiction: an update Subst Abus 29 2008 31 49
5. A.M. Elkashef, R.A. Rawson, A.L. Anderson, S.H. Li, T. Holmes, and E.V. Smith Bupropion for the treatment of methamphetamine dependence Neuropsychopharmacology 33 2008 1162 1170 (Pubitemid 351367539)
6. S.V. Faraone, J. Biederman, T. Spencer, D. Michelson, L. Adler, and F. Reimherr Atomoxetine and stroop task performance in adult attention-deficit/ hyperactivity disorder J Child Adolesc Psychopharmacol 15 2005 664 670 (Pubitemid 41434370)
7. A.E. Fleckenstein, J.W. Gibb, and G.R. Hanson Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity Eur J Pharmacol 406 2000 1 13
8. M. Haney, and R. Spealman Controversies in translational research: drug self-administration Psychopharmacology 199 2008 403 419
9. C.L. Hart, E.W. Gunderson, A. Perez, M.G. Kirkpatrick, A. Thurmond, and S.D. Comer Acute physiological and behavioral effects of intranasal methamphetamine in humans Neuropsychopharmacology 33 2008 1847 1855 (Pubitemid 351832594)
10. S.H. Heil, H.W. Holmes, W.K. Bickel, S.T. Higgins, G.J. Badger, and H.F. Laws Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users Drug Alcohol Depend 67 2002 149 156 (Pubitemid 34722402)
11. C.E. Johanson, and J.E. Barrett The discriminative stimulus effects of cocaine in pigeons J Pharmacol Exp Ther 267 1993 1 8 (Pubitemid 23324981)
12. C.E. Johanson, and M.W. Fischman The pharmacology of cocaine related to its abuse Pharmacol Rev 41 1989 3 52 (Pubitemid 19247826)
13. D. Jovanovski, S. Erb, and K.K. Zakzanis Neurocognitive deficits in cocaine users: a quantitative review of the evidence J Clin Exp Neuropsychol 27 2005 189 204 (Pubitemid 40389048)
14. L. Karila, A. Weinstein, H.J. Aubin, A. Benyamina, M. Reynaud, and S.L. Batki Pharmacological approaches to methamphetamine dependence: a focused review Br J Clin Pharmacol 69 2010 578 592
15. M.S. Kleven, E.W. Anthony, and W.L. Woolverton Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys J Pharmacol Exp Ther 254 1990 312 317 (Pubitemid 20262058)
16. R. Kuczenski, and D.S. Segal Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine J Neurochem 68 1997 2032 2037 (Pubitemid 27176139)
17. N.K. Lee, and R.A. Rawson A systematic review of cognitive and behavioural therapies for methamphetamine dependence Drug Alcohol Rev 27 2008 309 317
18. J.A. Lile, W.W. Stoops, T.M. Durell, P.E. Glaser, and C.R. Rush Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans Exp Clin Psychopharmacol 14 2006 136 147 (Pubitemid 43988631)
19. O. Lingjaerde, U.G. Ahlfors, P. Bech, S.J. Dencker, and K. Elgen The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients Acta Psychiatr Scand Suppl 334 1987 1 100 (Pubitemid 17115352)
20. D. Michelson, D. Faries, J. Wernicke, D. Kelsey, K. Kendrick, and F.R. Sallee Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study Pediatrics 108 2001 E83
21. D. Michelson, A.J. Allen, J. Busner, C. Casat, D. Dunn, and C. Kratochvil Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study Am J Psychiatry 159 2002 1896 1901 (Pubitemid 35283256)
22. D. Michelson, L. Adler, T. Spencer, F.W. Reimherr, S.A. West, and A.J. Allen Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies Biol Psychiatry 53 2003 112 120 (Pubitemid 36126473)
23. N. Nicosia, E. Reardon, K. Lorenz, J. Lynn, and M.B. Buntin The Medicare hospice payment system: a consideration of potential refinements Health Care Financ Rev 30 2009 47 59
24. A.H. Oliveto, W.K. Bickel, J.R. Hughes, P.J. Shea, S.T. Higgins, and J.W. Fenwick Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports J Pharmacol Exp Ther 261 1992 885 894
25. J. Pasic, J.E. Russo, R.K. Ries, and P.P. Roy-Byrne Methamphetamine users in the psychiatric emergency services: a case-control study Am J Drug Alcohol Abuse 33 2007 675 686 (Pubitemid 47463776)
26. P.G. Rendell, M. Mazur, and J.D. Henry Prospective memory impairment in former users of methamphetamine Psychopharmacology 203 2009 609 616
27. J.M. Roll, N.M. Petry, M.L. Stitzer, M.L. Brecht, J.M. Peirce, and M.J. McCann Contingency management for the treatment of methamphetamine use disorders Am J Psychiatry 163 2006 1993 1999 (Pubitemid 44807792)
28. R.B. Rothman, M.H. Baumann, C.M. Dersch, D.V. Romero, K.C. Rice, and F.I. Carroll Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin Synapse 39 2001 32 41
29. C.R. Rush, W.W. Stoops, and L.R. Hays Cocaine effects during d-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy Drug Alcohol Depend 99 2009 261 271
30. C.R. Rush, A.R. Vansickel, J.A. Lile, and W.W. Stoops Evidence-based treatment of amphetamine dependence: behavioral and pharmacological approaches L. Cohen, F.L. Collins, A.M. Young, D.E. McChargue, T.R. Leffingwell, K.L. Cook, Pharmacology and treatment of substance abuse: evidence- and outcome-based perspectives 2009 Routledge, Taylor and Francis Group New York 335 358
31. C.R. Rush, W.W. Stoops, J.A. Lile, P.E.A. Glaser, and L.R. Hays Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance Psychopharmacology 214 2011 665 674
32. R. Salo, T.E. Nordahl, Y. Natsuaki, M.H. Leamon, G.P. Galloway, and C. Waters Attentional control and brain metabolite levels in methamphetamine abusers Biol Psychiatry 61 2007 1272 1280 (Pubitemid 46726259)
33. M.L. Selzer The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument Am J Psychiatry 127 1971 1653 1658
34. R.J. Sevak, W.W. Stoops, L.R. Hays, and C.R. Rush Discriminative-stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate and triazolam in methamphetamine-trained humans J Pharmacol Exp Ther 328 2009 1007 1018
35. S. Shoptaw, J.D. Klausner, C.J. Reback, S. Tierney, J. Stansell, and C.B. Hare A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence BMC Public Health 6 2006 214
36. S. Shoptaw, K.G. Heinzerling, E. Rotheram-Fuller, T. Steward, J. Wang, and A.N. Swanson Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence Drug Alcohol Depend 96 2008 222 232
37. S. Shoptaw, W.D. King, E. Landstrom, M.A. Bholat, K. Heinzerling, and G.D. Victorianne Public health issues surrounding methamphetamine dependence. Methamphetamine addiction J.R. Roll, W. Ling, R.A. Rawson, S. Shoptaw, Basic science to treatment 2009 Guilford Press 143 156
38. D. Simpson, and G.L. Plosker Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder Drugs 64 2004 205 222 (Pubitemid 38186965)
39. D. Simpson, and G.L. Plosker Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder CNS Drugs 18 2004 397 401
40. H.A. Skinner The drug abuse screening test Addict Behav 7 1982 363 371 (Pubitemid 13162181)
41. M.F. Smout, M. Longo, S. Harrison, R. Minniti, W. Wickes, and J.M. White Psychosocial treatment for methamphetamine use disorders: a preliminary randomized controlled trial of cognitive behavior therapy and acceptance and commitment therapy Subst Abus 31 2010 98 107
42. M. Sofuoglu, J. Poling, K. Hill, and T. Kosten Atomoxetine attenuates dextroamphetamine effects in humans Am J Drug Alcohol Abuse 35 2009 412 416
43. R.D. Spealman Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys J Pharmacol Exp Ther 275 1995 53 62
44. W.W. Stoops, J.W. Blackburn, D.A. Hudson, L.R. Hays, and C.R. Rush Safety, tolerability and subject-rated effects of intranasal cocaine during atomoxetine maintenance Drug Alcohol Depend 92 2008 282 285 (Pubitemid 350213243)
45. Substance Abuse and Mental Health Services Administration, Office of Applied Studies Treatment Episode Data Set (TEDS) Highlights - 2007 National Admissions to Substance Abuse Treatment Services 2009 OAS Series #S-45, HHS Publication No. (SMA) 09-4360 Rockville, MD
46. E.A. van der Plas, E.A. Crone, W.P. van den Wildenberg, D. Tranel, and A. Bechara Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women J Clin Exp Neuropsychol 31 2009 706 719
47. F.J. Vocci, and N.M. Appel Approaches to the development of medications for the treatment of methamphetamine dependence Addiction 102 2007 96 106 (Pubitemid 46328210)
48. S. Wee, and W.L. Woolverton Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine Drug Alcohol Depend 75 2004 271 276 (Pubitemid 38993297)